Intelsense advisory subscription updates
First of all, wishing all of you a very Happy New Year.
Yesterday, SEBI came out with a new set of guidelines for registered Research Analysts. As a corporate RA, we need to comply with all the guidelines. There are many new directives which make it much more onerous and operationally challenging and take away from our core focus of investment research and learning. But there is nothing much to be done about it except to accept it and make the necessary changes as less disruptive as possible.
The main points and their impacts are as follows:
If you are interested in being a subscriber, please mail equity@intelsense.in, and we will notify you when subscriptions are open again.
To invest in our PMS for an investment corpus of 50 lakhs and more, drop us a line at equity@shreerama.co.in
DISCLAIMER:
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
SEBI Registered Research Analyst -Â Cupressus Enterprises Pvt Ltd - INH000013828.
Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors.